Sugi Predict

Sugi Predict / Compounds / SCHEMBL27707192

SCHEMBL27707192

SCHEMBL27707192

CC(Cl)C(=O)OC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KIF11 P52732 3/20 0.41
▸ KCNN4 O15554 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ CHRM3 P20309 3/20 0.40
▸ CHRM2 P08172 2/20 0.40
▸ CHRM1 P11229 2/20 0.40
▸ KCNH2 Q12809 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ GRIN2D O15399 2/20 0.37
▸ GRIN1 Q05586 2/20 0.37
▸ GRIN2A Q12879 2/20 0.37
▸ GRIN2B Q13224 2/20 0.37
▸ GRIN2C Q14957 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27587690 0.85 CYP1A2 (0.42) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL29697636 0.85 CYP1A2 (0.50) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL10464550 0.85 CYP1A2 (0.48) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL28120011 0.85 CYP1A2 (0.42) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL30800300 0.83 CYP1A2 (0.47) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL28995002 0.83 CYP1A2 (0.41) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL7722281 0.82 CYP1A2 (0.47) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL30534307 0.82 CYP1A2 (0.47) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL27687904 0.81 CYP1A2 (0.39) CYP2D6CYP1A2KMT2AMAPTKIF11
SCHEMBL7359300 0.81 CYP1A2 (0.46) CYP2D6CYP1A2KMT2AMAPTKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101563364-B Insulinotropic peptide synthesis HOFFMANN LA ROCHE 2014-04-02 — — CN disclosed
CN-101903400-B Insulinotropic peptide synthesis using solid and liquid phase combination techniques HOFFMANN LA ROCHE 2013-12-18 — — CN disclosed
CN-103189384-A Diketopiperazine forming dipeptidyl linker LONZA AG 2013-07-03 — — CN disclosed
CN-101133077-B Synthesis using peptide intermediate fragments HOFFMANN LA ROCHE 2012-09-05 — — CN disclosed
CN-101133078-B Synthesis of peptide T-20 using peptide intermediate fragments HOFFMANN LA ROCHE 2011-07-27 — — CN disclosed
CN-101133076-B Synthesis using peptide intermediate fragments HOFFMANN LA ROCHE 2011-07-13 — — CN disclosed
CN-101903400-A Insulinotropic peptide synthesis using solid and liquid phase combination techniques HOFFMANN LA ROCHE 2010-12-01 — — CN disclosed
CN-101835794-A Use the pancreotropic hormone method of peptide synthesis of solid phase and the combined technology of solution HOFFMANN LA ROCHE 2010-09-15 — — CN disclosed
CN-101573371-A Synthesis method of cyclic peptide compound HOFFMANN LA ROCHE (CH) 2009-11-04 — — CN disclosed
CN-101563364-A Insulinotropic peptide synthesis HOFFMANN LA ROCHE (CH) 2009-10-21 — — CN disclosed
CN-101133078-A Synthesis of peptide T-20 Using peptide intermediate fragments ROCHE COLORADO CORP (CH) 2008-02-27 — — CN disclosed
CN-101133076-A Synthesis using peptide intermediate fragments ROCHE COLORADO CORP (CH) 2008-02-27 — — CN disclosed
CN-101133077-A Synthesis using peptide intermediate fragments ROCHE COLORADO CORP (CH) 2008-02-27 — — CN disclosed